Table 2.
Author (year) | Relationship | Study method | Subjects (Number; Male, Female) | Period of stress evaluation/Thyroid status at the time of study |
---|---|---|---|---|
Gray et al. (1985) [49] | No | Interview Retrospective |
Thyrotoxicosis (50; M39, F11) Non-toxic goiter (50; M45, F5) |
6 months prior to the first symptoms Untreated patients |
Winsa et al. (1991) [42] | Yes | Questionnaire Retrospective |
Graves’ disease (208; M37, F171) Control (3 7 2) |
1 year prior to diagnosis Less than 2 weeks after diagnosis |
Sonin et al. (1993) [43] | Yes | Interview Retrospective |
Graves’ disease (70; M12, F58) Control (70) |
1 year prior to first signs Euthyroid after treatment |
Kun (1995) [44] | Yes | Questionnaire Retrospective |
Graves’ disease (95; M5, F80) Control (95) |
1 year prior to diagnosis Untreated patients |
Radosaljevic et al. (1996) [45] | Yes | Interview Retrospective |
Graves’ disease (100; M7, F93) Control (1 0 0) |
1 year prior to diagnosis Not available |
Yoshiuchi et al. (1998) [46] | Yes | Questionnaire Retrospective |
Graves’ disease (228; M46, F182) Control (2 2 8) |
1 year prior to diagnosis Within 1 month of diagnosis |
Martin-du Pan (1998) [50] | No | Graves’ disease (98; M12, F86) Hashimoto (95; M4, 女F91) Benign nodule (97; F97) |
||
Chiovato et al. (1998) [51] | No | Thyroid function Prospective |
Panic disorder (87; M17, F70) Control (2 6 2) |
1–30 years No Graves’ disease |
Matos-Santos et al. (2001) [47] | Yes | Interview Retrospective |
Graves’ disease (31; M9, F22) Toxic nodular goiter (31) Control (31) |
I year prior to first symptoms Euthyroid after treatment |
Effraimidis et al. (2011) [52] | No | Questionnaire Prospective |
Euthyroid women who were 1st and 2nd degree relatives of AITD patients (521; F521) | 2.7 ± 1.5 years Untreated patients |
Topcu et al. (2012) [48] | Yes | Interview Retrospective |
Graves’ disease (45; M12, F33) Toxic nodular goiter (24; M7, F17) Control (36) |
6 months prior to the first symptoms Or euthyroid after one year treatment |